Editor’s note: A livestream of this event will be posted below at 1 p.m. ET.
The Covid-19 pandemic has shown what happens when we let our guard down against infectious disease, despite years of increasingly loud warnings. So it’s time to be even more worried about antibiotic-resistant germs. What policy steps can fight this growing problem? STAT will convene policymakers, researchers, and corporate executives to chart a path to progress.
Sponsor Introduction: Kenneth E. Thorpe, professor of health policy at Emory University and chairman of the Partnership to Fight Infectious Disease
Part 1: Legislative Solutions
It’s obvious that D.C. needs to play a role in fixing this problem. What can be done? Sen. Bill Cassidy has some ideas.
- Sen. Bill Cassidy, M.D. (R-La.)
- Matthew Herper, senior writer, medicine; editorial director of events, STAT (moderator)
Part 2: Defining the problem
Why has this problem been so hard to solve? What are the consequences if we don’t find a solution? An expert discussion.
- Helen W. Boucher M.D., F.A.C.P., F.I.D.S.A., chief, Division of Geographic Medicine and Infectious Diseases; director, Levy Center for Integrated Management of Antimicrobial Resistance (CIMAR) at Tufts Medical Center
- Gail R. Hansen, D.V.M., M.P.H., senior consultant, Hansen Consulting LLC
- Evan Loh, M.D., chief executive officer, Paratek
- Ed Silverman, Pharmalot columnist, senior writer, STAT (moderator)